» Articles » PMID: 34512821

Saddle Pulmonary Embolism is Not a Sign of High-risk Deterioration in Non-high-risk Patients: A Propensity Score-matched Study

Overview
Specialty Emergency Medicine
Date 2021 Sep 13
PMID 34512821
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is controversy regarding whether saddle main pulmonary artery (MPA) embolism represents a high risk of deterioration in non-high-risk acute pulmonary embolism (PE) patients. This study aims to address this issue by conducting a propensity score matching (PSM) study.

Methods: A total of 727 non-high-risk acute PE patients were retrospectively evaluated. We evaluated the Bova score and risk stratification to examine the risk of deterioration. Deterioration defined as any adverse event within 30 days after admission. Computed tomographic pulmonary angiography was used to identify the embolism type. All patients were matched into four subgroups by PSM according to age, sex, Bova score, and risk stratification: (1) MPA and non-MPA embolism; (2) non-saddle MPA and non-MPA embolism; (3) saddle MPA and non-saddle MPA embolism; (4) saddle MPA and non-MPA embolism. Correlations were analyzed using Cox regression analysis, and deterioration risk was compared between subgroups using Kaplan-Meier analysis.

Results: Cox regression analysis revealed that MPA embolism was correlated with deterioration, regardless of whether saddle MPA embolism was included or excluded. Saddle MPA embolism was not correlated with deterioration, regardless of comparison with non-saddle MPA embolism or non-MPA embolism. Patients with MPA and non-saddle MPA embolism presented a high risk for deterioration (log-rank test=5.23 and 4.70, =0.022 and 0.030, respetively), while patients with saddle MPA embolism were not at a high risk of deterioration (log-rank test=1.20 and 3.17, =0.729 and 0.077, respetively).

Conclusions: Saddle MPA embolism is not indicative of a high risk of deterioration in non-high-risk acute PE patients.

Citing Articles

Increasing angiotensin-converting enzyme (ACE) 2/ACE axes ratio alleviates early pulmonary vascular remodeling in a porcine model of acute pulmonary embolism with cardiac arrest.

Xiao H, Zhao L, Yang J, Tong N, An L, Wang G World J Emerg Med. 2022; 13(3):208-214.

PMID: 35646211 PMC: 9108909. DOI: 10.5847/wjem.j.1920-8642.2022.052.


Comparison of two scores in predicting pulmonary embolism-related adverse events in intermediate-high-risk patients: a systematic review and meta-analysis.

Bova C, Vigna E, Gentile M, Pignataro F Intern Emerg Med. 2022; 17(5):1543-1546.

PMID: 35320490 DOI: 10.1007/s11739-022-02963-5.

References
1.
Zuin M, Rigatelli G, Zonzin P, Casazza F, Roncon L . Saddle pulmonary embolism in hemodynamically stable patients: To lyse or not to lyse? An issue in no guidelines land. Eur J Intern Med. 2017; 46:e26-e28. DOI: 10.1016/j.ejim.2017.09.002. View

2.
Beenen L, Bossuyt P, Stoker J, Middeldorp S . Prognostic value of cardiovascular parameters in computed tomography pulmonary angiography in patients with acute pulmonary embolism. Eur Respir J. 2018; 52(1). DOI: 10.1183/13993003.02611-2017. View

3.
Santos A, Freitas P, Ferreira J, Oliveira A, Goncalves M, Faria D . Risk stratification in normotensive acute pulmonary embolism patients: focus on the intermediate-high risk subgroup. Eur Heart J Acute Cardiovasc Care. 2019; 9(4):279-285. DOI: 10.1177/2048872619846506. View

4.
Liu M, Miao R, Guo X, Zhu L, Zhang H, Hou Q . Saddle Pulmonary Embolism: Laboratory and Computed Tomographic Pulmonary Angiographic Findings to Predict Short-term Mortality. Heart Lung Circ. 2016; 26(2):134-142. DOI: 10.1016/j.hlc.2016.02.019. View

5.
Fernandez C, Bova C, Sanchez O, Prandoni P, Lankeit M, Konstantinides S . Validation of a Model for Identification of Patients at Intermediate to High Risk for Complications Associated With Acute Symptomatic Pulmonary Embolism. Chest. 2015; 148(1):211-218. DOI: 10.1378/chest.14-2551. View